The UNC Eshelman School of Pharmacy is a key member of the robust research arm of the University of North Carolina at Chapel Hill.

Our faculty are leaders and innovators in their areas of research, and the School’s proximity to the Research Triangle Park and other research campuses spurs collaboration and partnerships in academia and with industry. Research at the School has spawned a number of spin-off companies, and in 2009, the School led the University with twenty-six invention disclosures and four patents received.

If you are looking for opportunities for research collaboration, please visit the Global Engagement section of our website, or explore our Eshelman Institute for Innovation’s resources for entrepreneurial development.

A Unique Perspective

The UNC Eshelman School of Pharmacy provides a unique perspective among peer institutions in our approach to research. The School conducts a wide range of advanced research that aligns with five phases of the drug discovery, development and delivery cycle.

Each phase is represented by a division within the School. Faculty and graduate students alike are encouraged to work with their peers within the School and the University to further realize research goals in discovery, preclinical and clinical development of therapeutic agents, optimum delivery of drug therapy, evaluation of health and therapeutic outcomes of novel drug therapies and technologies, as well as regulatory policies.

Download the Eshelman Institute for Innovation 2018 Annual Impact Report

The Eshelman Institute for Innovation was established in 2014 with a $100 million commitment from Dr. Fred Eshelman. The Institute provides grant funding to UNC Eshelman School of Pharmacy faculty who are collaborating with scientists, health care providers and educators both inside and outside UNC-Chapel Hill, including academia, industry and foundations.

  • Discovery Grants: Innovative research that has not been attempted before, but that has the potential to transform science, medicine, health care delivery or health care education.
  • Translational Grants: Research and development that validates transformative discovery findings via optimization and proof of principle or proof of commercial readiness.
  • Strategic Grants: High impact, multidisciplinary ideas that form the basis for transforming research programs, educational initiatives, the practice of health care, or operational practices within a health care setting.

Get the EII Annual Impact Report to learn more about the Institute and funding partnership opportunities.

website_cover_image

Recent Research News

Beaudoin, Vogt Earn NIH Predoctoral Research Grants

March 27, 2019

Two Ph.D. candidates at the UNC Eshelman School of Pharmacy recently received National Research Service Awards from the National Institutes of Health. Jim Beaudoin, from the Division of Pharmacotherapy and Experimental Therapeutics, and Caleb Vogt, from the Division of Chemical … Continued

Elizabeth Gurysh, Ph.D.

Gurysh Receives NIH F32 Grant for Brain Cancer Research

March 18, 2019

Elizabeth Gurysh, Ph.D., received a National Research Service Award from the National Institutes of Health to support her brain cancer research. Gurysh is a postdoctoral researcher working in the lab of Kristy Ainslie, Ph.D., at the UNC Eshelman School of … Continued


Read More